Diagnosis and management of bipolar disorders
FS Goes - bmj, 2023 - bmj.com
Bipolar disorders (BDs) are recurrent and sometimes chronic disorders of mood that affect
around 2% of the world's population and encompass a spectrum between severe elevated …
around 2% of the world's population and encompass a spectrum between severe elevated …
Prevention of suicidal behavior in bipolar disorder
L Tondo, GH Vázquez, RJ Baldessarini - Bipolar disorders, 2021 - Wiley Online Library
Background Excess mortality is a critical hallmark of bipolar disorder (BD) due to co‐
occurring general medical disorders and especially from suicide. It is timely to review of the …
occurring general medical disorders and especially from suicide. It is timely to review of the …
Treatment-resistant bipolar depression: therapeutic trends, challenges and future directions
Introduction Bipolar disorder (BD) is a chronic mental illness impacting 1–2% of the
population worldwide and causing high rates of functional impairment. Patients with BD …
population worldwide and causing high rates of functional impairment. Patients with BD …
[HTML][HTML] Bipolar depression: a review of treatment options
K Levenberg, ZA Cordner - General Psychiatry, 2022 - ncbi.nlm.nih.gov
Bipolar depression (BD-D) is both common and incredibly challenging to treat. Even treated
individuals with BD-D experience depression approximately 19% of the time, and …
individuals with BD-D experience depression approximately 19% of the time, and …
Vagus nerve stimulation: An update on a novel treatment for treatment-resistant depression
LY Kamel, W Xiong, BM Gott, A Kumar… - Journal of the …, 2022 - Elsevier
In this review, we provide an overview of essential clinical trials examining the effect of vagal
nerve stimulation (VNS) in treatment-resistant depression (TRD), the applicable …
nerve stimulation (VNS) in treatment-resistant depression (TRD), the applicable …
Brain stimulation treatment for bipolar disorder
J Mutz - Bipolar Disorders, 2023 - Wiley Online Library
Aims Bipolar disorders are clinically complex, chronic and recurrent disorders. Few
treatment options are effective across hypomanic, manic, depressive and mixed states and …
treatment options are effective across hypomanic, manic, depressive and mixed states and …
[HTML][HTML] Baseline characteristics of a European patient population with difficult-to-treat depression (RESTORE-LIFE) treated with adjunctive vagus nerve stimulation
K Demyttenaere, T Costa, E Kavakbasi, M Jiang… - Journal of affective …, 2024 - Elsevier
Background Major depressive disorder is a complex heterogeneous disorder. Treatment is
especially challenging for patients with “difficult-to-treat depression”(DTD): a less …
especially challenging for patients with “difficult-to-treat depression”(DTD): a less …
Vagus nerve stimulation in patients receiving maintenance therapy with electroconvulsive therapy: a series of 10 cases
ST Aaronson, EL Goldwaser, DJ Kutzer… - The Journal of …, 2021 - journals.lww.com
Objectives Electroconvulsive therapy (ECT) is a mainstay in both acute and long-term
management of difficult-to-treat depression. However, frequent acute courses of ECT or …
management of difficult-to-treat depression. However, frequent acute courses of ECT or …
[HTML][HTML] Gut microbial dysbiosis and cognitive impairment in bipolar disorder: Current evidence
W Dai, Y Qiu, Z Teng, S Li, J Huang, H Tang… - Frontiers in …, 2022 - frontiersin.org
Recent studies have reported that the gut microbiota influences mood and cognitive function
through the gut-brain axis, which is involved in the pathophysiology of neurocognitive and …
through the gut-brain axis, which is involved in the pathophysiology of neurocognitive and …
[HTML][HTML] Setting up a successful vagus nerve stimulation service for patients with difficult-to-treat depression
C Kraus, D Quach, DM Sholtes, E Kavakbasi… - … : Technology at the …, 2022 - Elsevier
Background A substantial number of patients with major depressive disorder (MDD) do not
sufficiently remit after the first lines of antidepressant treatments, making them vulnerable to …
sufficiently remit after the first lines of antidepressant treatments, making them vulnerable to …